{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["N/A"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001005820"],"sample_count":["48"],"description":["EGA dataset EGAD00001005820"],"repository":["EGA"],"title":["Spatial RNA-sequencing of metastatic melanoma"],"name_synonyms":["Vasp, VASP, Data Set., DmelCG15112, ENHANCER OF ATNSI ACTIVITY, MENA, NDPP1, l(2)02029, Enb, enb, ENA, Ena, CG15112, ENA/VASP"],"description_synonyms":["Ribonucleic, DmelCG9412, RNA Sequence Determination, Transcriptome Profile, Sequence Determination, RNA Sequence, number, Gene Expression Profile, Gene, Profiles, aligned, presence, RPL23, Gene Products, Analysis, cytopathology, Non Polyadenylated, RNA Gene Products, Genomes., Ly101, Biopsies, Analyses, Determination, Nts, Profile, inhibiteur, cg9412, Sequence Determinations, CD279, Signatures, Sequencing, Non-Polyadenylated RNA, Pdc1, inhibidor, RNA Sequence Analyses, ROC2, Roc2, Expression Signature, Transcriptomes, RNA Sequencing, L17, metastatic malignant melanoma, HHT1, Sequence Analyses, inhibitors, RNA, Transcriptome, SLEB2, Edg, ribose nucleic acid, RNA Sequence Determinations, RIBA, Expression Profiles, ribonucleic acids, l17, inhibitor, aligned to, RNS, Determinations, Gene Expression, count in organism, rpl17a, pd-1, yeast nucleic acid, Ribonukleinsaeure, Expression Signatures, Gene Expression Signatures, pentosenucleic acids, Ribonucleic acids, Gene Expression Signature, metastatic melanoma, CG9412, END, Expression Profile, PD1, PD-1, Transcriptome Profiles, antagonists, ribonucleic acid, Acid, histopathology, Non Polyadenylated RNA, Non-Polyadenylated, 60S ribosomal protein L23, rpl23, Ribonucleic Acid, whole genome, hPD-1, hPD-l, antagonists and inhibitors, Gene Expression Profiles, RNA Sequence Analysis, hSLE1, rpl17, cardinality, Rin, RIN, Signature, biopsy, ORW1, rasp"],"additional_accession":[]},"is_claimable":false,"name":"ena-DATASET-MDACC-27-01-2020-21:13:33:933-258 - samples","description":"We performed RNA sequencing of 48 different regions sub-sampled from a metastatic melanoma biopsy that was treated with anti-PD-1 inhibitor. RNAseq was performed on samples with a minimum RNA integrity number (RIN) of 5.5 except for two cases (6A10 and 8A3) with RINs greater than 3. A minimum of 700ng of RNA were required for all samples undergoing RNAseq. Paired-end transcriptome reads were aligned using TopHat2, to the UCSC hg19 reference genome.","dates":{"updated":"2020-03-05 08:39:39"},"accession":"EGAD00001005820","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001001446","EGAS00001003292"]}}